Advertisement

Index by author

June 01, 2020; Volume 97,Issue 6

B

  1. Bean, Bruce P.

    1. Lidocaine Binding Enhances Inhibition of Nav1.7 Channels by the Sulfonamide PF-05089771
      Sooyeon Jo and Bruce P. Bean
      Molecular Pharmacology June 2020, 97 (6) 377-383; DOI: https://doi.org/10.1124/mol.119.118380

  2. Bian, Tengfei

    1. CXL146, a Novel 4<em>H</em>-Chromene Derivative, Targets GRP78 to Selectively Eliminate Multidrug-Resistant Cancer Cells
      CXL146, a Novel 4H-Chromene Derivative, Targets GRP78 to Selectively Eliminate Multidrug-Resistant Cancer Cells
      Tengfei Bian, Abderrahmane Tagmount, Amin Sobh, Christopher Vulpe, Kavitha Chandagirikoppal Vijendra and Chengguo Xing
      Molecular Pharmacology June 2020, 97 (6) 402-408; DOI: https://doi.org/10.1124/mol.119.118745

  3. Bouley, Renee A.

    1. A New Paroxetine-Based GRK2 Inhibitor Reduces Internalization of the <em>μ</em>-Opioid Receptor
      A New Paroxetine-Based GRK2 Inhibitor Reduces Internalization of the μ-Opioid Receptor
      Renee A. Bouley, Zara Y. Weinberg, Helen V. Waldschmidt, Yu-Chen Yen, Scott D. Larsen, Manojkumar A. Puthenveedu and John J.G. Tesmer
      Molecular Pharmacology June 2020, 97 (6) 392-401; DOI: https://doi.org/10.1124/mol.119.118661

D

  1. Delisle, Brian P.

    1. LUF7244 plus Dofetilide Rescues Aberrant Kv11.1 Trafficking and Produces Functional IKv11.1
      Muge Qile, Yuan Ji, Tyona D. Golden, Marien J.C. Houtman, Fee Romunde, Doreth Fransen, Willem B. van Ham, Ad P. IJzerman, Craig T. January, Laura H. Heitman, Anna Stary-Weinzinger, Brian P. Delisle and Marcel A.G. van der Heyden
      Molecular Pharmacology June 2020, 97 (6) 355-364; DOI: https://doi.org/10.1124/mol.119.118190

F

  1. Fan, Yunzhou

    1. Proteasome Inhibitors Bortezomib and Carfilzomib Stimulate the Transport Activity of Human Organic Anion Transporter 1
      Yunzhou Fan and Guofeng You
      Molecular Pharmacology June 2020, 97 (6) 384-391; DOI: https://doi.org/10.1124/mol.119.118653

  2. Fransen, Doreth

    1. LUF7244 plus Dofetilide Rescues Aberrant Kv11.1 Trafficking and Produces Functional IKv11.1
      Muge Qile, Yuan Ji, Tyona D. Golden, Marien J.C. Houtman, Fee Romunde, Doreth Fransen, Willem B. van Ham, Ad P. IJzerman, Craig T. January, Laura H. Heitman, Anna Stary-Weinzinger, Brian P. Delisle and Marcel A.G. van der Heyden
      Molecular Pharmacology June 2020, 97 (6) 355-364; DOI: https://doi.org/10.1124/mol.119.118190

G

  1. Golden, Tyona D.

    1. LUF7244 plus Dofetilide Rescues Aberrant Kv11.1 Trafficking and Produces Functional IKv11.1
      Muge Qile, Yuan Ji, Tyona D. Golden, Marien J.C. Houtman, Fee Romunde, Doreth Fransen, Willem B. van Ham, Ad P. IJzerman, Craig T. January, Laura H. Heitman, Anna Stary-Weinzinger, Brian P. Delisle and Marcel A.G. van der Heyden
      Molecular Pharmacology June 2020, 97 (6) 355-364; DOI: https://doi.org/10.1124/mol.119.118190

  2. Gros, Robert

    1. Proteinase-Activated Receptor 4 Activation Triggers Cell Membrane Blebbing through RhoA and β-Arrestin
      Christina M.G. Vanderboor, Pierre E. Thibeault, Kevin C.J. Nixon, Robert Gros, Jamie Kramer and Rithwik Ramachandran
      Molecular Pharmacology June 2020, 97 (6) 365-376; DOI: https://doi.org/10.1124/mol.119.118232

  3. Groundwater, Paul W.

    1. Tubulin-Binding 3,5-Bis(styryl)pyrazoles as Lead Compounds for the Treatment of Castration-Resistant Prostate Cancer
      Vivian W.Y. Liao, Anuradha Kumari, Rajeshwar Narlawar, Soma Vignarajan, David E. Hibbs, Dulal Panda and Paul W. Groundwater
      Molecular Pharmacology June 2020, 97 (6) 409-422; DOI: https://doi.org/10.1124/mol.119.118539

H

  1. Heitman, Laura H.

    1. LUF7244 plus Dofetilide Rescues Aberrant Kv11.1 Trafficking and Produces Functional IKv11.1
      Muge Qile, Yuan Ji, Tyona D. Golden, Marien J.C. Houtman, Fee Romunde, Doreth Fransen, Willem B. van Ham, Ad P. IJzerman, Craig T. January, Laura H. Heitman, Anna Stary-Weinzinger, Brian P. Delisle and Marcel A.G. van der Heyden
      Molecular Pharmacology June 2020, 97 (6) 355-364; DOI: https://doi.org/10.1124/mol.119.118190

  2. Hibbs, David E.

    1. Tubulin-Binding 3,5-Bis(styryl)pyrazoles as Lead Compounds for the Treatment of Castration-Resistant Prostate Cancer
      Vivian W.Y. Liao, Anuradha Kumari, Rajeshwar Narlawar, Soma Vignarajan, David E. Hibbs, Dulal Panda and Paul W. Groundwater
      Molecular Pharmacology June 2020, 97 (6) 409-422; DOI: https://doi.org/10.1124/mol.119.118539

  3. Houtman, Marien J.C.

    1. LUF7244 plus Dofetilide Rescues Aberrant Kv11.1 Trafficking and Produces Functional IKv11.1
      Muge Qile, Yuan Ji, Tyona D. Golden, Marien J.C. Houtman, Fee Romunde, Doreth Fransen, Willem B. van Ham, Ad P. IJzerman, Craig T. January, Laura H. Heitman, Anna Stary-Weinzinger, Brian P. Delisle and Marcel A.G. van der Heyden
      Molecular Pharmacology June 2020, 97 (6) 355-364; DOI: https://doi.org/10.1124/mol.119.118190

I

  1. IJzerman, Ad P.

    1. LUF7244 plus Dofetilide Rescues Aberrant Kv11.1 Trafficking and Produces Functional IKv11.1
      Muge Qile, Yuan Ji, Tyona D. Golden, Marien J.C. Houtman, Fee Romunde, Doreth Fransen, Willem B. van Ham, Ad P. IJzerman, Craig T. January, Laura H. Heitman, Anna Stary-Weinzinger, Brian P. Delisle and Marcel A.G. van der Heyden
      Molecular Pharmacology June 2020, 97 (6) 355-364; DOI: https://doi.org/10.1124/mol.119.118190

J

  1. January, Craig T.

    1. LUF7244 plus Dofetilide Rescues Aberrant Kv11.1 Trafficking and Produces Functional IKv11.1
      Muge Qile, Yuan Ji, Tyona D. Golden, Marien J.C. Houtman, Fee Romunde, Doreth Fransen, Willem B. van Ham, Ad P. IJzerman, Craig T. January, Laura H. Heitman, Anna Stary-Weinzinger, Brian P. Delisle and Marcel A.G. van der Heyden
      Molecular Pharmacology June 2020, 97 (6) 355-364; DOI: https://doi.org/10.1124/mol.119.118190

  2. Ji, Yuan

    1. LUF7244 plus Dofetilide Rescues Aberrant Kv11.1 Trafficking and Produces Functional IKv11.1
      Muge Qile, Yuan Ji, Tyona D. Golden, Marien J.C. Houtman, Fee Romunde, Doreth Fransen, Willem B. van Ham, Ad P. IJzerman, Craig T. January, Laura H. Heitman, Anna Stary-Weinzinger, Brian P. Delisle and Marcel A.G. van der Heyden
      Molecular Pharmacology June 2020, 97 (6) 355-364; DOI: https://doi.org/10.1124/mol.119.118190

  3. Jo, Sooyeon

    1. Lidocaine Binding Enhances Inhibition of Nav1.7 Channels by the Sulfonamide PF-05089771
      Sooyeon Jo and Bruce P. Bean
      Molecular Pharmacology June 2020, 97 (6) 377-383; DOI: https://doi.org/10.1124/mol.119.118380

K

  1. Kramer, Jamie

    1. Proteinase-Activated Receptor 4 Activation Triggers Cell Membrane Blebbing through RhoA and β-Arrestin
      Christina M.G. Vanderboor, Pierre E. Thibeault, Kevin C.J. Nixon, Robert Gros, Jamie Kramer and Rithwik Ramachandran
      Molecular Pharmacology June 2020, 97 (6) 365-376; DOI: https://doi.org/10.1124/mol.119.118232

  2. Kumari, Anuradha

    1. Tubulin-Binding 3,5-Bis(styryl)pyrazoles as Lead Compounds for the Treatment of Castration-Resistant Prostate Cancer
      Vivian W.Y. Liao, Anuradha Kumari, Rajeshwar Narlawar, Soma Vignarajan, David E. Hibbs, Dulal Panda and Paul W. Groundwater
      Molecular Pharmacology June 2020, 97 (6) 409-422; DOI: https://doi.org/10.1124/mol.119.118539

L

  1. Larsen, Scott D.

    1. A New Paroxetine-Based GRK2 Inhibitor Reduces Internalization of the <em>μ</em>-Opioid Receptor
      A New Paroxetine-Based GRK2 Inhibitor Reduces Internalization of the μ-Opioid Receptor
      Renee A. Bouley, Zara Y. Weinberg, Helen V. Waldschmidt, Yu-Chen Yen, Scott D. Larsen, Manojkumar A. Puthenveedu and John J.G. Tesmer
      Molecular Pharmacology June 2020, 97 (6) 392-401; DOI: https://doi.org/10.1124/mol.119.118661

  2. Liao, Vivian W.Y.

    1. Tubulin-Binding 3,5-Bis(styryl)pyrazoles as Lead Compounds for the Treatment of Castration-Resistant Prostate Cancer
      Vivian W.Y. Liao, Anuradha Kumari, Rajeshwar Narlawar, Soma Vignarajan, David E. Hibbs, Dulal Panda and Paul W. Groundwater
      Molecular Pharmacology June 2020, 97 (6) 409-422; DOI: https://doi.org/10.1124/mol.119.118539

N

  1. Narlawar, Rajeshwar

    1. Tubulin-Binding 3,5-Bis(styryl)pyrazoles as Lead Compounds for the Treatment of Castration-Resistant Prostate Cancer
      Vivian W.Y. Liao, Anuradha Kumari, Rajeshwar Narlawar, Soma Vignarajan, David E. Hibbs, Dulal Panda and Paul W. Groundwater
      Molecular Pharmacology June 2020, 97 (6) 409-422; DOI: https://doi.org/10.1124/mol.119.118539

  2. Nixon, Kevin C.J.

    1. Proteinase-Activated Receptor 4 Activation Triggers Cell Membrane Blebbing through RhoA and β-Arrestin
      Christina M.G. Vanderboor, Pierre E. Thibeault, Kevin C.J. Nixon, Robert Gros, Jamie Kramer and Rithwik Ramachandran
      Molecular Pharmacology June 2020, 97 (6) 365-376; DOI: https://doi.org/10.1124/mol.119.118232

P

  1. Panda, Dulal

    1. Tubulin-Binding 3,5-Bis(styryl)pyrazoles as Lead Compounds for the Treatment of Castration-Resistant Prostate Cancer
      Vivian W.Y. Liao, Anuradha Kumari, Rajeshwar Narlawar, Soma Vignarajan, David E. Hibbs, Dulal Panda and Paul W. Groundwater
      Molecular Pharmacology June 2020, 97 (6) 409-422; DOI: https://doi.org/10.1124/mol.119.118539

  2. Puthenveedu, Manojkumar A.

    1. A New Paroxetine-Based GRK2 Inhibitor Reduces Internalization of the <em>μ</em>-Opioid Receptor
      A New Paroxetine-Based GRK2 Inhibitor Reduces Internalization of the μ-Opioid Receptor
      Renee A. Bouley, Zara Y. Weinberg, Helen V. Waldschmidt, Yu-Chen Yen, Scott D. Larsen, Manojkumar A. Puthenveedu and John J.G. Tesmer
      Molecular Pharmacology June 2020, 97 (6) 392-401; DOI: https://doi.org/10.1124/mol.119.118661

Q

  1. Qile, Muge

    1. LUF7244 plus Dofetilide Rescues Aberrant Kv11.1 Trafficking and Produces Functional IKv11.1
      Muge Qile, Yuan Ji, Tyona D. Golden, Marien J.C. Houtman, Fee Romunde, Doreth Fransen, Willem B. van Ham, Ad P. IJzerman, Craig T. January, Laura H. Heitman, Anna Stary-Weinzinger, Brian P. Delisle and Marcel A.G. van der Heyden
      Molecular Pharmacology June 2020, 97 (6) 355-364; DOI: https://doi.org/10.1124/mol.119.118190

R

  1. Ramachandran, Rithwik

    1. Proteinase-Activated Receptor 4 Activation Triggers Cell Membrane Blebbing through RhoA and β-Arrestin
      Christina M.G. Vanderboor, Pierre E. Thibeault, Kevin C.J. Nixon, Robert Gros, Jamie Kramer and Rithwik Ramachandran
      Molecular Pharmacology June 2020, 97 (6) 365-376; DOI: https://doi.org/10.1124/mol.119.118232

  2. Romunde, Fee

    1. LUF7244 plus Dofetilide Rescues Aberrant Kv11.1 Trafficking and Produces Functional IKv11.1
      Muge Qile, Yuan Ji, Tyona D. Golden, Marien J.C. Houtman, Fee Romunde, Doreth Fransen, Willem B. van Ham, Ad P. IJzerman, Craig T. January, Laura H. Heitman, Anna Stary-Weinzinger, Brian P. Delisle and Marcel A.G. van der Heyden
      Molecular Pharmacology June 2020, 97 (6) 355-364; DOI: https://doi.org/10.1124/mol.119.118190

S

  1. Sobh, Amin

    1. CXL146, a Novel 4<em>H</em>-Chromene Derivative, Targets GRP78 to Selectively Eliminate Multidrug-Resistant Cancer Cells
      CXL146, a Novel 4H-Chromene Derivative, Targets GRP78 to Selectively Eliminate Multidrug-Resistant Cancer Cells
      Tengfei Bian, Abderrahmane Tagmount, Amin Sobh, Christopher Vulpe, Kavitha Chandagirikoppal Vijendra and Chengguo Xing
      Molecular Pharmacology June 2020, 97 (6) 402-408; DOI: https://doi.org/10.1124/mol.119.118745

  2. Stary-Weinzinger, Anna

    1. LUF7244 plus Dofetilide Rescues Aberrant Kv11.1 Trafficking and Produces Functional IKv11.1
      Muge Qile, Yuan Ji, Tyona D. Golden, Marien J.C. Houtman, Fee Romunde, Doreth Fransen, Willem B. van Ham, Ad P. IJzerman, Craig T. January, Laura H. Heitman, Anna Stary-Weinzinger, Brian P. Delisle and Marcel A.G. van der Heyden
      Molecular Pharmacology June 2020, 97 (6) 355-364; DOI: https://doi.org/10.1124/mol.119.118190

T

  1. Tagmount, Abderrahmane

    1. CXL146, a Novel 4<em>H</em>-Chromene Derivative, Targets GRP78 to Selectively Eliminate Multidrug-Resistant Cancer Cells
      CXL146, a Novel 4H-Chromene Derivative, Targets GRP78 to Selectively Eliminate Multidrug-Resistant Cancer Cells
      Tengfei Bian, Abderrahmane Tagmount, Amin Sobh, Christopher Vulpe, Kavitha Chandagirikoppal Vijendra and Chengguo Xing
      Molecular Pharmacology June 2020, 97 (6) 402-408; DOI: https://doi.org/10.1124/mol.119.118745

  2. Tesmer, John J.G.

    1. A New Paroxetine-Based GRK2 Inhibitor Reduces Internalization of the <em>μ</em>-Opioid Receptor
      A New Paroxetine-Based GRK2 Inhibitor Reduces Internalization of the μ-Opioid Receptor
      Renee A. Bouley, Zara Y. Weinberg, Helen V. Waldschmidt, Yu-Chen Yen, Scott D. Larsen, Manojkumar A. Puthenveedu and John J.G. Tesmer
      Molecular Pharmacology June 2020, 97 (6) 392-401; DOI: https://doi.org/10.1124/mol.119.118661

  3. Thibeault, Pierre E.

    1. Proteinase-Activated Receptor 4 Activation Triggers Cell Membrane Blebbing through RhoA and β-Arrestin
      Christina M.G. Vanderboor, Pierre E. Thibeault, Kevin C.J. Nixon, Robert Gros, Jamie Kramer and Rithwik Ramachandran
      Molecular Pharmacology June 2020, 97 (6) 365-376; DOI: https://doi.org/10.1124/mol.119.118232

V

  1. Vanderboor, Christina M.G.

    1. Proteinase-Activated Receptor 4 Activation Triggers Cell Membrane Blebbing through RhoA and β-Arrestin
      Christina M.G. Vanderboor, Pierre E. Thibeault, Kevin C.J. Nixon, Robert Gros, Jamie Kramer and Rithwik Ramachandran
      Molecular Pharmacology June 2020, 97 (6) 365-376; DOI: https://doi.org/10.1124/mol.119.118232

  2. van der Heyden, Marcel A.G.

    1. LUF7244 plus Dofetilide Rescues Aberrant Kv11.1 Trafficking and Produces Functional IKv11.1
      Muge Qile, Yuan Ji, Tyona D. Golden, Marien J.C. Houtman, Fee Romunde, Doreth Fransen, Willem B. van Ham, Ad P. IJzerman, Craig T. January, Laura H. Heitman, Anna Stary-Weinzinger, Brian P. Delisle and Marcel A.G. van der Heyden
      Molecular Pharmacology June 2020, 97 (6) 355-364; DOI: https://doi.org/10.1124/mol.119.118190

  3. van Ham, Willem B.

    1. LUF7244 plus Dofetilide Rescues Aberrant Kv11.1 Trafficking and Produces Functional IKv11.1
      Muge Qile, Yuan Ji, Tyona D. Golden, Marien J.C. Houtman, Fee Romunde, Doreth Fransen, Willem B. van Ham, Ad P. IJzerman, Craig T. January, Laura H. Heitman, Anna Stary-Weinzinger, Brian P. Delisle and Marcel A.G. van der Heyden
      Molecular Pharmacology June 2020, 97 (6) 355-364; DOI: https://doi.org/10.1124/mol.119.118190

  4. Vignarajan, Soma

    1. Tubulin-Binding 3,5-Bis(styryl)pyrazoles as Lead Compounds for the Treatment of Castration-Resistant Prostate Cancer
      Vivian W.Y. Liao, Anuradha Kumari, Rajeshwar Narlawar, Soma Vignarajan, David E. Hibbs, Dulal Panda and Paul W. Groundwater
      Molecular Pharmacology June 2020, 97 (6) 409-422; DOI: https://doi.org/10.1124/mol.119.118539

  5. Vijendra, Kavitha Chandagirikoppal

    1. CXL146, a Novel 4<em>H</em>-Chromene Derivative, Targets GRP78 to Selectively Eliminate Multidrug-Resistant Cancer Cells
      CXL146, a Novel 4H-Chromene Derivative, Targets GRP78 to Selectively Eliminate Multidrug-Resistant Cancer Cells
      Tengfei Bian, Abderrahmane Tagmount, Amin Sobh, Christopher Vulpe, Kavitha Chandagirikoppal Vijendra and Chengguo Xing
      Molecular Pharmacology June 2020, 97 (6) 402-408; DOI: https://doi.org/10.1124/mol.119.118745

  6. Vulpe, Christopher

    1. CXL146, a Novel 4<em>H</em>-Chromene Derivative, Targets GRP78 to Selectively Eliminate Multidrug-Resistant Cancer Cells
      CXL146, a Novel 4H-Chromene Derivative, Targets GRP78 to Selectively Eliminate Multidrug-Resistant Cancer Cells
      Tengfei Bian, Abderrahmane Tagmount, Amin Sobh, Christopher Vulpe, Kavitha Chandagirikoppal Vijendra and Chengguo Xing
      Molecular Pharmacology June 2020, 97 (6) 402-408; DOI: https://doi.org/10.1124/mol.119.118745

W

  1. Waldschmidt, Helen V.

    1. A New Paroxetine-Based GRK2 Inhibitor Reduces Internalization of the <em>μ</em>-Opioid Receptor
      A New Paroxetine-Based GRK2 Inhibitor Reduces Internalization of the μ-Opioid Receptor
      Renee A. Bouley, Zara Y. Weinberg, Helen V. Waldschmidt, Yu-Chen Yen, Scott D. Larsen, Manojkumar A. Puthenveedu and John J.G. Tesmer
      Molecular Pharmacology June 2020, 97 (6) 392-401; DOI: https://doi.org/10.1124/mol.119.118661

  2. Weinberg, Zara Y.

    1. A New Paroxetine-Based GRK2 Inhibitor Reduces Internalization of the <em>μ</em>-Opioid Receptor
      A New Paroxetine-Based GRK2 Inhibitor Reduces Internalization of the μ-Opioid Receptor
      Renee A. Bouley, Zara Y. Weinberg, Helen V. Waldschmidt, Yu-Chen Yen, Scott D. Larsen, Manojkumar A. Puthenveedu and John J.G. Tesmer
      Molecular Pharmacology June 2020, 97 (6) 392-401; DOI: https://doi.org/10.1124/mol.119.118661

X

  1. Xing, Chengguo

    1. CXL146, a Novel 4<em>H</em>-Chromene Derivative, Targets GRP78 to Selectively Eliminate Multidrug-Resistant Cancer Cells
      CXL146, a Novel 4H-Chromene Derivative, Targets GRP78 to Selectively Eliminate Multidrug-Resistant Cancer Cells
      Tengfei Bian, Abderrahmane Tagmount, Amin Sobh, Christopher Vulpe, Kavitha Chandagirikoppal Vijendra and Chengguo Xing
      Molecular Pharmacology June 2020, 97 (6) 402-408; DOI: https://doi.org/10.1124/mol.119.118745

Y

  1. Yen, Yu-Chen

    1. A New Paroxetine-Based GRK2 Inhibitor Reduces Internalization of the <em>μ</em>-Opioid Receptor
      A New Paroxetine-Based GRK2 Inhibitor Reduces Internalization of the μ-Opioid Receptor
      Renee A. Bouley, Zara Y. Weinberg, Helen V. Waldschmidt, Yu-Chen Yen, Scott D. Larsen, Manojkumar A. Puthenveedu and John J.G. Tesmer
      Molecular Pharmacology June 2020, 97 (6) 392-401; DOI: https://doi.org/10.1124/mol.119.118661

  2. You, Guofeng

    1. Proteasome Inhibitors Bortezomib and Carfilzomib Stimulate the Transport Activity of Human Organic Anion Transporter 1
      Yunzhou Fan and Guofeng You
      Molecular Pharmacology June 2020, 97 (6) 384-391; DOI: https://doi.org/10.1124/mol.119.118653
Back to top

In this issue

Advertisement